ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Entia Biosciences Inc (EM)

Entia Biosciences Inc (EM) (ERGO)

0,0002
0,00
( 0,00% )
Aktualisiert: 02:00:00

Entia Biosciences Inc (EM) (ERGO) Aktie

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
0,0002
( - )
Gebot
0,00
Fragen
0,00
Volumen
-
0,00 Tagesbereich 0,00
0,0001 52-Wochen-Bereich 0,0403
Marktkapitalisierung
Handelsende
0,0002
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
-
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
US$ 3.175
Ausgegebene Aktien
34.060.882
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-0,01
Gewinn pro Aktie (EPS)
-0,05
Erlöse (LTM)
265,47k
Nettogewinn (LTM)
-1,4M

Über Entia Biosciences Inc (EM)

Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical food products in the United States. The company develops ErgoD2, a pharmaceutical grade organic compound for the improvement of iron homeostasis and mitigation of iron... Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical food products in the United States. The company develops ErgoD2, a pharmaceutical grade organic compound for the improvement of iron homeostasis and mitigation of iron-related disorders presenting in anemia, chronic kidney disease, and select neurodegenerative diseases. It is also involved in the discovery, scientific evaluation, and marketing of natural formulations that can be used in medical food, nutraceuticals, cosmetics, and other products. In addition, the company offers beauty products under the GROH brand name. It markets its products directly to consumers through e-commerce channels, such as direct email marketing, social media outlets, and e-commerce sites. The company was formerly known as Total Nutraceutical Solutions, Inc. and changed its name to Entia Biosciences, Inc. in January 2012. Entia Biosciences, Inc. was incorporated in 2007 and is headquartered in Sherwood, Oregon. Mehr anzeigen

Sektor
Healthcare
Branche
Biotechnology & Life Sciences
Hauptsitz
Sherwood, United States
Gegründet
2026
Entia Biosciences Inc (EM) is listed in the Healthcare sector of the OTC Markets with ticker ERGO. The last closing price for Entia Biosciences (EM) was US$0,00. Over the last year, Entia Biosciences (EM) shares have traded in a share price range of US$ 0,0001 to US$ 0,0403.

Entia Biosciences (EM) currently has 34.060.882 shares in issue. The market capitalisation of Entia Biosciences (EM) is US$6.812,18 . Entia Biosciences (EM) has a price to earnings ratio (PE ratio) of -0.01.

ERGO Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1000.00020.00020.00021830.0002CS
4000.00020.00020.00021830.0002CS
12-0.0004-66.66666666670.00060.00060.000118520.00058488CS
26-0.0001-33.33333333330.00030.04030.000117170.00112548CS
520.00011000.00010.04030.000127260.00052995CS
156000.00020.04031.0E-689310.00015502CS
260-0.1448-99.86206896550.1450.1991.0E-6884960.08341116CS

ERGO - Frequently Asked Questions (FAQ)

What is the current Entia Biosciences Inc (EM) share price?
The current share price of Entia Biosciences Inc (EM) is US$ 0,0002
How many Entia Biosciences Inc (EM) shares are in issue?
Entia Biosciences Inc (EM) has 34.060.882 shares in issue
What is the market cap of Entia Biosciences Inc (EM)?
The market capitalisation of Entia Biosciences Inc (EM) is USD 6,81k
What is the 1 year trading range for Entia Biosciences Inc (EM) share price?
Entia Biosciences Inc (EM) has traded in the range of US$ 0,0001 to US$ 0,0403 during the past year
What is the PE ratio of Entia Biosciences Inc (EM)?
The price to earnings ratio of Entia Biosciences Inc (EM) is -0,01
What is the cash to sales ratio of Entia Biosciences Inc (EM)?
The cash to sales ratio of Entia Biosciences Inc (EM) is 0,08
What is the registered address of Entia Biosciences Inc (EM)?
The registered address for Entia Biosciences Inc (EM) is 13565 SW Tualatin-Sherwood Road, Sherwood, Oregon, 97140
Which industry sector does Entia Biosciences Inc (EM) operate in?
Entia Biosciences Inc (EM) operates in the Biotechnology & Life Sciences sector

ERGO Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen